Related Articles
Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo
miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma Retraction in /10.3892/ijo.2021.5280
RAS protein activator‑like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor‑1α
Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals
RASAL1 inhibits HepG2 cell growth via HIF‑2α mediated gluconeogenesis